CERS (Cerus Corp) Stock Analysis - Hedge Fund Holdings
Cerus Corp (CERS) is a publicly traded Healthcare sector company. As of May 21, 2026, CERS trades at $2.65 with a market cap of $486.90M and a P/E ratio of -33.19. CERS moved -0.19% today. Year to date, CERS is +31.22%; over the trailing twelve months it is +100.75%. Its 52-week range spans $1.12 to $3.15. Analyst consensus is strong buy with an average price target of $4.50. Rallies surfaces CERS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns CERS stock?
Hedge funds tracked by Rallies that own CERS include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cerus Corp.
CERS Key Metrics
Key financial metrics for CERS
Metric
Value
Price
$2.65
Market Cap
$486.90M
P/E Ratio
-33.19
EPS
$-0.08
Dividend Yield
0.00%
52-Week High
$3.15
52-Week Low
$1.12
Volume
13
Avg Volume
0
Revenue (TTM)
$233.80M
Net Income
$-15.64M
Gross Margin
0.00%
Top Hedge Funds Holding CERS
Panagora Asset holds 305.25K shares of CERS, changed +229.99% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own CERS include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cerus Corp.
Does Rallies show 13F holders for CERS?
Yes. Rallies tracks hedge fund and 13F ownership data for CERS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CERS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CERS. It does not provide personalized investment advice.
